390 filings
Page 7 of 20
8-K
9jexe4fkwsb rd
17 Jun 20
Regulation FD Disclosure
8:30am
DEFA14A
by5mut 1cquf8
27 May 20
Additional proxy soliciting materials
9:15am
8-K
vxhgfg3zsb 88tw
14 May 20
Pulmatrix Reports Q1 2020 Results
9:11am
DEFA14A
9k8p14 idushak91axc
29 Apr 20
Additional proxy soliciting materials
9:03am
8-K
5crd7b2vyg6x20fp620t
24 Apr 20
Regulation FD Disclosure
4:26pm
D
m0t6ob8mq7t7rp09nsvr
24 Apr 20
$8.07M in options / securities to be acquired, sold $8.07M, 3 investors
1:48pm
8-K
vhak 5ctdk4ml5ombg
22 Apr 20
Departure of Directors or Certain Officers
1:06pm
8-K
7b8dn7
20 Apr 20
Entry into a Material Definitive Agreement
6:26am
424B5
c2r848rm6 d0
20 Apr 20
Prospectus supplement for primary offering
6:22am
8-K
853f23bsrwb4mnby0
16 Apr 20
Pulmatrix Announces $8.0 Million Registered Direct Offering
5:27pm
8-K
yk2xmfbm
16 Apr 20
Pulmatrix and Sensory Cloud Announce Partnership to Develop and Commercialize
8:37am
8-K
esgepdz 5nba
15 Apr 20
Entry into a Material Definitive Agreement
5:02pm
8-K
jm0nj
6 Apr 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
6:21am
8-K
drgadeh6go2kntpx
26 Mar 20
Pulmatrix Reports 2019 Financial Results and Provides Business Update
9:05am
8-K
utrywg ia
30 Jan 20
Pulmatrix Receives Fast Track Designation for Pulmazole for the Treatment of Asthma-ABPA
10:18am
8-K
ltkgqfy
16 Jan 20
Other Events
12:12pm
8-K
hxz86uujuqm9 tomuj
13 Jan 20
Regulation FD Disclosure
8:45am